A recent survey of radiologists indicates that current AI tools for breast cancer detection are not meeting expectations. While many radiologists are using these FDA-approved tools, they are not seeing the anticipated improvements in recall rates or reductions in unnecessary biopsies. The study highlights a significant gap between the promised capabilities of AI in diagnostics and the actual clinical outcomes. AI
IMPACT Current AI tools for breast cancer detection are not yet delivering on promised improvements in diagnostic efficiency and accuracy for radiologists.
RANK_REASON The cluster discusses the performance and user satisfaction of existing AI tools in a specific application, rather than a new release or fundamental research.
- AI tools for breast cancer detection
- biopsy
- Breast Cancer Detection: Comparison of Breast Tomosynthesis and Conventional Mammography
- radiologist
- Society of Breast Imaging
- FDA
AI-generated summary · Google Gemini · from 2 sources. How we write summaries →
